Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 38 → 39·22:33, 4 Aug 2025
Difference between revision 38 and revision 39 of Shanghai Wibson Biotechnology. 3 lines changed; the page grew by 280 bytes.
| Revision 38 — 20:35, 27 Jul 2025 BlindSampleBrid (talk) convert prose to table for comparability 7,498 bytes ±0 | Revision 39 — 22:33, 4 Aug 2025 TallySheetTad (talk) attribute range as a review estimate per talk 7,778 bytes +280 | ||
|---|---|---|---|
| 58 | The absence of water figures on the accompanying certificates is the substantive documentation gap in this set: a purity figure alone constrains the ''relative'' composition of what dissolved and says nothing about how much peptide the vial held.{{r|usp1503}} As elsewhere, samples were purchaser-selected rather than [[Blind sampling|blind-drawn]], so the reports cannot be read as a sample of output.{{r|reports}} | 58 | The absence of water figures on the accompanying certificates is the substantive documentation gap in this set: a purity figure alone constrains the ''relative'' composition of what dissolved and says nothing about how much peptide the vial held.{{r|usp1503}} As elsewhere, samples were purchaser-selected rather than [[Blind sampling|blind-drawn]], so the reports cannot be read as a sample of output.{{r|reports}} |
| 59 | 59 | ||
| + | 60 | == Reception == | |
| + | 61 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring positive themes are responsiveness and delivery times; recurring complaints concern certificate depth.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} | |
| + | 62 | ||
| 60 | == References == | 63 | == References == |
| 61 | {{reflist}} | 64 | {{reflist}} |